All In MedTech

Device Trial Radar · NCT03624257

Comparing Two Treatment Modalities of Peri-implantitis - Blue Laser (445 nm) and Conventional Flap Surgery

Last checked: Nov 20, 2026Latest source record: Jul 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Sep 2018

Primary completion

Jun 2020

Study completion Jun 2020

Sponsor

Lead sponsor
Sirona Dental Systems GmbHNot on our public-company list
Sponsor type
Industry
First posted
Aug 10, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A clinical trial comparing laser treatment and conventional mucosal flap surgery for treatment of peri-implantitis. The main aim of the study is to evaluate if treatment of peri-implantitis with a novel blue laser (445 nm) combined with scaling and root planning (SRP) is clinically comparable to conventional mucosal flap surgery in terms of pocket probing depth reduction.

Conditions

  • Peri-Implantitis

Interventions

  • Laser treatmentDevice

    The participants in the laser group are treated by a combination of scaling and root planning (SRP) and 445 nm diode laser. The peri-implant pocket will be radiated with the 445 nm laser, removing bacteria, diseased epithelium and granulation tissue. The Power setting on the laser will be 0.7 W continuous wave and will be used at maximum 20 s Before cooling water is applied. Total treatment time will vary with the depth of the pocket and size of the surrounding bone crater.

  • Mucosal flap surgeryProcedure

    The participants will receive a conventional peri-implant mucosal flap surgery of affected implants, in combination with scaling and root planning (SRP), and return after 7-10 days for suture removal. The surgery is a well-established treatment of peri-implantitis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline in Pocket probing depth (PPD) at 6 months after treatment.Time frame: At baseline and 6 months post treatment

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Danakliniken Specialist Dentistry, Mörby Centrum floor 5

    Danderyd, Sweden

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.